In this article, we are going to take a look at where ImmunityBio, Inc. (NASDAQ:IBRX) stands against the other stocks. Wall Street finished the trading week stronger, posting gains by more than 1 ...

We recently compiled a list of the 12 Stocks Under $10 With High Upside Potential. In this article, we are going to take a ...

CULVER CITY, Calif., March 13, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation’s ...

ImmunityBio Trading Down 1.0 % Shares of IBRX stock opened at $2.87 on Friday. ImmunityBio has a twelve month low of $2.28 and a twelve month high of $10.53. The stock has a market capitalization ...

Shares of IBRX stock opened at $2.87 on Thursday. ImmunityBio has a twelve month low of $2.28 and a twelve month high of $10.53. The stock has a market capitalization of $2.45 billion, a price-to ...

ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...

SAN DIEGO — SAN DIEGO — ImmunityBio, Inc. (IBRX) on Monday reported a loss of $59.2 million in its fourth quarter. The San Diego-based company said it had a loss of 9 cents per share. Losses, adjusted ...

Highlights,The New York State Common Retirement Fund raised its stake in ImmunityBio by 62.8% in the fourth quarter.,Several institutional players, including State Street Corp and Barclays PLC, made ...